Binhui Bio received 300 million RMB B+ round of financing
Binhui Bio is a research and development manufacturer of anti-tumor drugs. Its main product is recombinant oncolytic type II herpes simplex virus (OH2) injection, which is suitable for lung cancer, head and neck tumors, lymphoma, liver cancer, melanoma and other diseases. It can be used in combination with traditional radiotherapy and chemotherapy to improve efficacy […]
Binhui Bio received 300 million RMB B+ round of financing Read More »